[ad_1]
Bring your questions about the new weight loss drug for the stars, semaglutide (Ozempic is indicated for treating type 2 diabetes and Wegovy for weight management).
It shows:
- Jeremy Faust, MD, editor-in-chief of MedPage Today (@jeremysamuelfaust)
- Karl Nadolsky, DO, clinical assistant professor of medicine, MSU College of Human Medicine (@drkarlnadolsky)
- Fatima Cody Stanford, MD, MPH, MPA, MBA, associate professor of medicine and pediatrics, Harvard Medical School (@askdrfatima)
How do I enroll? Follow @MedPage on Instagram!
When is the event? Tune in Monday, November 14, at 12 pm ET.
Can I ask a question? Yes, we encourage questions! Submit your pre-event questions by commenting below.
Related articles:
An In-Depth Look at Hollywood’s Newest Weight Loss Pill
The demand for ‘Bootlegged’ Heavy-Duty Games is on the rise
Weight-Loss Drug Dropped Expectations, and Supply
FDA OKs Injectable Semaglutide for Chronic Weight Management
‘Mind Blowing’ Results in Heavy-Duty Testing
[ad_2]
Source link